Cargando…

A Dual Adjuvant System for Intranasal Boosting of Local and Systemic Immunity for Influenza Vaccination

Systemically vaccinated individuals against COVID-19 and influenza may continue to support viral replication and shedding in the upper airways, contributing to the spread of infections. Thus, a vaccine regimen that enhances mucosal immunity in the respiratory mucosa is needed to prevent a pandemic....

Descripción completa

Detalles Bibliográficos
Autores principales:	Sato-Kaneko, Fumi, Yao, Shiyin, Lao, Fitzgerald S., Sako, Yukiya, Jin, Jasmine, Shukla, Nikunj M., Cottam, Howard B., Chan, Michael, Belsuzarri, Masiel M., Carson, Dennis A., Hayashi, Tomoko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611830/ https://www.ncbi.nlm.nih.gov/pubmed/36298559 http://dx.doi.org/10.3390/vaccines10101694

Ejemplares similares

Identification of a Novel Small Molecule That Enhances the Release of Extracellular Vesicles with Immunostimulatory Potency via Induction of Calcium Influx
por: Sako, Yukiya, et al.
Publicado: (2023)

Small Molecule Calcium Channel Activator Potentiates Adjuvant Activity
por: Saito, Tetsuya, et al.
Publicado: (2022)

Small Molecule Potentiator of Adjuvant Activity Enhancing Survival to Influenza Viral Challenge
por: Saito, Tetsuya, et al.
Publicado: (2021)

A Triple High Throughput Screening for Extracellular Vesicle Inducing Agents With Immunostimulatory Activity
por: Shukla, Nikunj M., et al.
Publicado: (2022)

Discovery of a Novel Microtubule Targeting Agent as an Adjuvant for Cancer Immunotherapy
por: Sato-Kaneko, Fumi, et al.
Publicado: (2018)

A Novel Synthetic Dual Agonistic Liposomal TLR4/7 Adjuvant Promotes Broad Immune Responses in an Influenza Vaccine With Minimal Reactogenicity
por: Sato-Kaneko, Fumi, et al.
Publicado: (2020)

Generation and Application of a Reporter Cell Line for the Quantitative Screen of Extracellular Vesicle Release
por: Shpigelman, Jonathan, et al.
Publicado: (2021)

Identification of Compounds With Glucocorticoid Sparing Effects on Suppression of Chemokine and Cytokine Production by Rheumatoid Arthritis Fibroblast-Like Synoviocytes
por: Hosoya, Tadashi, et al.
Publicado: (2020)

Mast Cell-Mediated Inhibition of Abdominal Neutrophil Inflammation by a PEGylated TLR7 Ligand
por: Hayashi, Tomoko, et al.
Publicado: (2012)

Treatment of Autoimmune Inflammation by a TLR7 Ligand Regulating the Innate Immune System
por: Hayashi, Tomoko, et al.
Publicado: (2012)

Induction of Tolerogenic Dendritic Cells by a PEGylated TLR7 Ligand for Treatment of Type 1 Diabetes
por: Hayashi, Tomoko, et al.
Publicado: (2015)

Cytokines: The Future of Intranasal Vaccine Adjuvants
por: Thompson, Afton L., et al.
Publicado: (2011)

Identification of Substituted Pyrimido[5,4-b]indoles as Selective Toll-Like Receptor 4 Ligands
por: Chan, Michael, et al.
Publicado: (2013)

The intranasal adjuvant Endocine™ enhances both systemic and mucosal immune responses in aged mice immunized with influenza antigen
por: Falkeborn, Tina, et al.
Publicado: (2017)

Multicomponent intranasal adjuvant for mucosal and durable systemic SARS-CoV-2 immunity in young and aged mice
por: Jangra, Sonia, et al.
Publicado: (2023)

Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System
por: Ciabattini, Annalisa, et al.
Publicado: (2018)

The mucosal and systemic immune responses elicited by a chitosan‐adjuvanted intranasal influenza H5N1 vaccine
por: Svindland, Signe C., et al.
Publicado: (2011)

IL-33 Is Essential for Adjuvant Effect of Hydroxypropyl-β-Cyclodexrin on the Protective Intranasal Influenza Vaccination
por: Kobari, Shingo, et al.
Publicado: (2020)

Intranasal mesenchymal stem cell therapy to boost myelination after encephalopathy of prematurity
por: Vaes, Josine E. G., et al.
Publicado: (2020)

Characterization of the Antigen-Specific CD4(+) T Cell Response Induced by Prime-Boost Strategies with CAF01 and CpG Adjuvants Administered by the Intranasal and Subcutaneous Routes
por: Ciabattini, Annalisa, et al.
Publicado: (2015)

Intranasal SARS-CoV-2 spike-based immunisation adjuvanted with polyethyleneimine elicits mucosal and systemic humoral responses in mice
por: Deimel, Lachlan P., et al.
Publicado: (2022)

Intranasal nanoemulsion adjuvanted S-2P vaccine demonstrates protection in hamsters and induces systemic, cell-mediated and mucosal immunity in mice
por: Ganesan, Shyamala, et al.
Publicado: (2022)

Intranasal Delivery of Influenza Subunit Vaccine Formulated with GEM Particles as an Adjuvant
por: Saluja, Vinay, et al.
Publicado: (2010)

The Efficacy of Intranasal Desmopressin as an Adjuvant in the Acute Renal Colic Pain Management
por: Masoumi, Kambiz, et al.
Publicado: (2014)

Design and Application in Delivery System of Intranasal Antidepressants
por: Xu, Jingying, et al.
Publicado: (2020)

Synthesis and Immunological Characterization of Toll-Like Receptor 7 Agonistic Conjugates
por: Chan, Michael, et al.
Publicado: (2009)

Fusion-Expressed CTB Improves Both Systemic and Mucosal T-Cell Responses Elicited by an Intranasal DNA Priming/Intramuscular Recombinant Vaccinia Boosting Regimen
por: Qiu, Sugan, et al.
Publicado: (2014)

Investigating Prime-Pull Vaccination through a Combination of Parenteral Vaccination and Intranasal Boosting
por: Roces, Carla B., et al.
Publicado: (2019)

Evaluation of Recent Intranasal Drug Delivery Systems to the Central Nervous System
por: Crowe, Tyler P., et al.
Publicado: (2022)

Characterization of Systemic and Mucosal Humoral Immune Responses to an Adjuvanted Intranasal SARS-CoV-2 Protein Subunit Vaccine Candidate in Mice
por: Maltseva, Mariam, et al.
Publicado: (2022)

Intranasal Liposomal Formulation of Spike Protein Adjuvanted with CpG Protects and Boosts Heterologous Immunity of hACE2 Transgenic Mice to SARS-CoV-2 Infection
por: Russo, Momtchilo, et al.
Publicado: (2023)

Protective efficacy of intranasal inactivated pseudorabies vaccine is improved by combination adjuvant in mice
por: Hua, Tao, et al.
Publicado: (2022)

Biodistribution and Adjuvant Effect of an Intranasal Vaccine Based on Chitosan Nanoparticles against Paracoccidioidomycosis
por: Santos Júnior, Samuel Rodrigues Dos, et al.
Publicado: (2023)

Intranasal Treatment of Central Nervous System Dysfunction in Humans
por: Chapman, Colin D., et al.
Publicado: (2012)

Harnessing Intranasal Delivery Systems of Sumatriptan for the Treatment of Migraine
por: Assadpour, Sara, et al.
Publicado: (2022)

Intranasal Delivery of Liposomes to Glioblastoma by Photostimulation of the Lymphatic System
por: Semyachkina-Glushkovskaya, Oxana, et al.
Publicado: (2022)

Intranasal H5N1 Vaccines, Adjuvanted with Chitosan Derivatives, Protect Ferrets against Highly Pathogenic Influenza Intranasal and Intratracheal Challenge
por: Mann, Alex J., et al.
Publicado: (2014)

Glucopyranosyl Lipid Adjuvant (GLA), a Synthetic TLR4 Agonist, Promotes Potent Systemic and Mucosal Responses to Intranasal Immunization with HIVgp140
por: Arias, Mauricio A., et al.
Publicado: (2012)

Adjuvant radiotherapy with brachytherapy boost in soft tissue sarcomas
por: Cortesi, Annalisa, et al.
Publicado: (2017)

Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses
por: Hasegawa, Hideki, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_a1fti5pajiue4be45rubj59u5b